The margin of sampling error including the design effect for the full sample is plus or minus 3 percentage points
GLP-1 treatment can be an important healthcare decision, and consumers deserve simple, transparent information about how providers compare, what medications may be available, what costs to expect, and what signs indicate a legitimate, medically supervised program
Learn more about the federally funded science breakthroughs that changed everything in The New York Times: #GLP1 #UMSOM #BasicScience #FederalFunding #BiomedicalInnovation #DiabetesResearch #ObesityTreatment #SciencePolicy How Gila monster venom led to GLP-1 medications Millions of Americans are now benefiting from GLP-1 medications like Ozempic and Wegovybut few know the story began with a venomous lizard and a federally funded research project
Target-trial-emulation and cohort analyses report that diabetic patients on GLP-1R agonists develop dementia and Alzheimers disease at lower rates than those on comparator antidiabetic drugs, and pooled analyses of cardiovascular-outcome trials have pointed in the same direction [9]
The right choice depends on health history, medication use, personal tolerance, and medical guidance
A.XuP.VerveridisF